A healthcare investing prediction: The world becomes fickle
Hey startup CEO: How will you need to think differently about protecting your assets in a way that allows you to build value in the long term?
Healthcare entrepreneurs trust no one (and that’s why they’re brilliant)
There are plenty of good investors out there, but many will pull a Mr. Hyde act to get what they want from healthcare entrepreneurs.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Read the MedCity News survey on corporate venture capital in healthcare
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.
Another way to mitigate risk in healthcare venture capital
We all want the 12x, but what happens when you're the 1x - and how do you make sure nothing goes wrong?
A financial analysis of litigation funding
Through litigation finance, CFOs can manage a dormant asset: potential litigation.
How to protect your business in the changing medtech landscape
Last week, I discussed the changing landscape of medtech innovation, and how shifting dynamics in the capital raising process have led young businesses to be more vulnerable to unscrupulous partners and mal-intentioned competitors. This week I will begin discussing how distressed venture funding and litigation finance can be used to help protect these innovating young […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The changing landscape of medtech innovation
Unfortunately, it is not uncommon for larger corporations to invest in promising healthcare companies, only to take advantage of their position by developing the underlying technology themselves or dispensing with the project so as to avoid cannibalizing sales.
How to raise capital in a difficult situation
Distressed venture finance and litigation finance are relatively new financial products that can help otherwise vulnerable businesses protect themselves. Companies, such as Lake Whillans, that provide these products can help businesses threatened by others' unscrupulous actions.